Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia

Launched by SHAHLA KAREEM ALALAF · Nov 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether certain markers in the blood of pregnant women can help detect preeclampsia early. Preeclampsia is a condition that can occur during pregnancy, causing high blood pressure and potential complications for both the mother and baby. By looking at these markers, researchers hope to find better ways to identify women at risk for preeclampsia, which could lead to earlier intervention and better care.

To join the trial, women must be between the ages of 18 and 45 and diagnosed with preeclampsia between 26 and 41 weeks of pregnancy. They can be having their first baby or have had previous pregnancies, and it doesn't matter if they are having one baby or more. However, women with certain health conditions, like chronic high blood pressure or diabetes, cannot participate. If they choose to take part, participants will provide blood samples and may receive more information about their health during the study. This research is currently looking for volunteers, so if you meet the criteria and are interested, it could be a valuable opportunity to contribute to important medical knowledge.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age group 18-45 years
• • Gestational age of 26-41 weeks at the time of diagnosis for preeclampsia
• • Delivered vaginally or abdominally
• • Being of any parity (para 1 and more)
• • Pregnancy being singleton or multiple pregnancies
• • Willingness to provide informed consent
• Exclusion Criteria:
• • Pregnant woman having chronic hypertension
• • Having Diabetes mellitus
• • The lady on medications that can affect inflammatory markers or blood pressure
• • Pregnant with fetal anomalies
• • Refused to involve in the research